These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6591944)

  • 1. Neutrophils with ring-shaped nuclei in myeloproliferative disease.
    Langenhuijsen MM
    Br J Haematol; 1984 Oct; 58(2):227-30. PubMed ID: 6591944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils with ring-shaped nuclei in chronic neutrophilic leukemia.
    Kanoh T; Saigo K; Yamagishi M
    Am J Clin Pathol; 1986 Dec; 86(6):748-51. PubMed ID: 3466524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three transcobalamins in myeloproliferative disorders and acute leukaemia.
    Zittoun J; Zittoun R; Marquet J; Sultan C
    Br J Haematol; 1975 Nov; 31(3):287-98. PubMed ID: 1059479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum beta-2-microglobulin in disorders of myeloid proliferation.
    Norfolk DR; Child JA; Roberts BE; Forbes MA; Cooper EH
    Acta Haematol; 1983; 69(6):361-8. PubMed ID: 6190339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders.
    Catovsky D; Galton DA; Griffin C; Hoffbrand AV; Szur L
    Br J Haematol; 1971 Dec; 21(6):661-72. PubMed ID: 5289350
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative cytochemistry of blood neutrophils in myelodysplastic syndromes and chronic granulocytic leukaemia.
    Schofield KP; Stone PC; Kelsey P; Leyland MJ; Stuart J
    Cell Biochem Funct; 1983 Jul; 1(2):92-6. PubMed ID: 6090032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural features of abnormal blood platelets. A review.
    White JG; Gerrard JM
    Am J Pathol; 1976 Jun; 83(3):589-632. PubMed ID: 779493
    [No Abstract]   [Full Text] [Related]  

  • 8. Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes.
    Munker R; Midis G; Owen-Schaub L; Andreff M
    Leukemia; 1996 Sep; 10(9):1531-3. PubMed ID: 8751476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring-shaped nuclei in human neutrophilic leukocytes of healthy individuals: evidence of their occurrence and characteristics.
    Cabral HR; Robert GB
    Am J Hematol; 1989 Apr; 30(4):259-60. PubMed ID: 2467556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors.
    Biermann H; Pietz B; Dreier R; Schmid KW; Sorg C; Sunderkötter C
    J Leukoc Biol; 1999 Feb; 65(2):217-31. PubMed ID: 10088605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders.
    Steensma DP; Porcher JC; Hanson CA; Lathrop CL; Hoyer JD; Lasho TA; Tefferi A; Higgs DR
    Br J Haematol; 2007 Nov; 139(3):439-42. PubMed ID: 17910635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte dysfunction in hematological disorders.
    Matzner Y
    Cancer Invest; 1992; 10(2):155-61. PubMed ID: 1551025
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of chronic-granulocytic-leukaemia leucocytes to release an inhibition of granulopoiesis.
    Philip MA; Standen G; Fletcher J
    Lancet; 1981 Apr; 1(8225):866-8. PubMed ID: 6112295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibronectin in myeloproliferative disorders and chronic granulocytic leukaemia.
    Norfolk DR; Bowen M; Roberts BE; Child JA
    Br J Haematol; 1983 Oct; 55(2):319-24. PubMed ID: 6577912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood coagulation and fibrinolysis in chronic myeloproliferative syndromes].
    Takahashi K; Shibata A
    Rinsho Ketsueki; 1980 May; 21(5):577-86. PubMed ID: 6997548
    [No Abstract]   [Full Text] [Related]  

  • 18. [Granulocyte dysfunction in hematological diseases].
    Matzner Y
    Gematol Transfuziol; 1993 May; 38(5):41-4. PubMed ID: 8034174
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro CFU-mix in peripheral blood of myeloproliferative disorders stimulated by serum of aplastic anemia (author's transl)].
    Aoki I; Toyama K; Okamoto S; Young CD
    Rinsho Ketsueki; 1982 Jan; 23(1):46-52. PubMed ID: 6980301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunocytochemical determination of lactoferrin from secondary granules of polynuclear neutrophils].
    Florensa Brichs L; Woessner Casas S; Lufuente Rodés R
    Med Clin (Barc); 1983 Jul; 81(5):228-30. PubMed ID: 6621167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.